DFine Announces The Appointment of Mr. Kevin Mosher To The Position of CEO

Spine

DFine Announces The Appointment of Mr. Kevin Mosher To The Position of CEO

SAN JOSE, Calif.–(Business Wire)– DFine Inc., the World’s leading developer of Radio Frequency Kyphoplasty products, minimally invasive solutions for treating vertebracompression fractures (VCFs), today announced the appointment of Mr. Kevin Mosher, as ChiefExecutive Officer, effective November 16, 2009. Mr. Mosher comes to DFine from Nobel Biocare, where he served as […]

Uncategorized

Premier Awards Non-Invasive Orthopaedics Agreement to Ossur

ALISO VIEJO, CA–(Marketwire – November 3, 2009) – Ossur, a global leader in non-invasive orthopaedics, announced today that it has been awarded a multi-year contract with Premier Purchasing Partners, the group purchasing unit of Premier, Inc. Premier consists of approximately 2,200 not-for-profit hospitals and healthcare systems, including large systems operating […]

Biologics

BioMimetic Therapeutics Receives First Orthopedic Marketing Approval for Augment™ Bone Graft

FRANKLIN, Tenn.–(BUSINESS WIRE)–BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that it has received approval from Health Canada to begin the marketing of its lead orthopedic product, Augment™ Bone Graft, as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion indications in Canada. “After rigorous pre-clinical and […]

Financial Spine

Spinal Modulation Completes $27.4 Million Financing

MENLO PARK, Calif.–(BUSINESS WIRE)–Spinal Modulation, Inc. announced today the completion of its $27.4 million Series C financing. Johnson & Johnson Development Corporation (JJDC) joined existing major investors including DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, and MedVenture Associates in this financing. DFJ/InCube Ventures and Raffles Venture Partners are additional […]

Biologics Sports Medicine

Biologic Response to Orthopedic Sutures: A Histologic Study in a Rabbit Model

Abstract Biologic reactivity to suture materials can have an effect on patient outcomes. The goal of this study was to determine the histologic response to 8 commonly used orthopedic sutures—Ethibond (Ethicon, Somerville, New Jersey), Ticron (Tyco, Waltham, Massachusetts), HiFi (Linvatec, Largo, Florida), Ultrabraid (Smith & Nephew, Memphis, Tennessee), MaxBraid (Biomet, […]

Biologics Financial Spine

Osiris Therapeutics Achieves $15 Million Milestone Payment

COLUMBIA, Md.–(BUSINESS WIRE)–Osiris Therapeutics, Inc. (NASDAQ: OSIR – News), today announced that the company has achieved a $15 million milestone payment from NuVasive (NASDAQ: NUVA – News) related to the sale of the Osteocel business. Triggering the payment, NuVasive recently reached $35 million in cumulative sales of Osteocel. With this […]

Spine

K2M Enters Japanese Spine Market

LEESBURG, Va.–(BUSINESS WIRE)–K2M, Inc., the spinal device company developing innovative and simplified solutions for the treatment of complex spinal pathologies and procedures, today announced it has entered the Japanese spine market via its breakthrough MESA® Spinal System. Similar to 510(k) clearance in the United States, the PMDA clearance allows for […]

Biologics Financial Sports Medicine

The ChondroCelect Harvester™ receives CE mark approval

The registration of the ChondroCelect Harvester™ follows the recent approval of ChondroCelect in Europe as the first cell-based product for cartilage repair to have received a European marketing authorization. ChondroCelect consists of characterized cultured chondrocytes derived from the patient’s own cartilage. The process of producing ChondroCelect starts with a small […]